河北医科大学学报 ›› 2023, Vol. 44 ›› Issue (10): 1152-1156.doi: 10.3969/j.issn.1007-3205.2023.10.007

• • 上一篇    下一篇

miR-133a、miR-182-5p与脓毒症患者肠屏障以及预后的关系

  

  1. 河北省保定市第一中心医院重症医学科,河北 保定 071000

  • 出版日期:2023-10-25 发布日期:2023-11-03
  • 作者简介:王肖肖(1993-),女,河北保定人,河北省保定市第一中心医院主治医师,医学硕士,从事脓毒症诊治研究。
  • 基金资助:
    保定市科技计划项目(18ZF236)

Relationship of miR-133a and miR-182-5p with intestinal barrier and prognosis in patients with sepsis

  1. Department of Critical Care Medicine, the First Central Hospital of Baoding, Hebei Province, Baoding 071000,China

  • Online:2023-10-25 Published:2023-11-03

摘要: 目的 探讨血清微小RNA-133a(microRNA-13a,miR-133a)、微小RNA-182-5p(microRNA-182-5p,miR-182-5p)与脓毒症患者肠屏障以及预后的关系。
方法 选取我院收治的150例脓毒症患者,入院时采用急性生理与慢性健康评分Ⅱ(acute physiology and chronic health evaluation,APACHEⅡ)及脓毒症临床症状评分指南,将患者分为轻中度脓毒症组79例和重度脓毒症组71例。根据患者30 d预后情况,将患者分为存活组102例和死亡组48例。入院时采集患者空腹静脉血标本,采用实时荧光定量聚合酶链式反应(polymerase chain reaction,PCR) 检测血清miR-133a、miR-182-5p表达水平。采用酶联免疫吸附试验检测患者血清肠脂肪酸结合蛋白(intestinal fatty acid binding protein,IFABP)、二胺氧化酶(diamine oxidase,DAO)、D-乳酸(D-lacticacid,D-LAC)等肠屏障功能指标水平。分析血清miR-133a、miR-182-5p表达与脓毒症患者肠屏障及预后的关系。
结果 轻中度脓毒症组血清IFABP、DAO、D-LAC等肠屏障功能指标和血清miR-133a水平低于重度脓毒症组(t=39.268、11.414、13.187、3.815,P<0.05),而血清miR-182-5p水平高于重度脓毒症组(t=130.137,P<0.05)。Pearson相关性分析结果显示,血清miR-133a水平与IFABP、DAO、D-LAC呈正相关关系(r=0.421、0.437、0.507,P<0.01),血清miR-182-5p水平与IFABP、DAO、D-LAC呈负相关关系(r=-0.433、-0.462、-0.497,P<0.01)。存活组血清miR-133a水平低于死亡组(t=10.126,P<0.05),而血清miR-182-5p水平高于死亡组(t=23.979,P<0.05)。多因素Logistic回归分析,结果显示,miR-133a升高(OR=2.303,95%CI:1.453~3.650)、miR-133a降低(OR=1.772,95%CI:1.167~2.690)是脓毒症患者预后的影响因素(P<0.05)。
结论  脓毒症患者血清miR-133a升高,miR-182V5p降低,其水平与患者肠屏障功能密切相关,对患者病情及预后评估具有重要参考价值。


关键词: 脓毒症, 循环微RNA, 预后

Abstract: Objective To investigate the relationship of serum microRNA-133a (miR-133a) and microRNA-182-5p (miR-182-5p) with intestinal barrier and prognosis in patients with sepsis. 
Methods A total of 150 patients with sepsis admitted to our hospital were selected and divided into mild to moderate sepsis group (n=79) and severe sepsis group (n=71) according to acute physiology and chronic health evaluation Ⅱ (APACHE Ⅱ) and the guidelines for clinical symptoms of sepsis on admission. According to the prognosis of the patients within 30 d, the patients were divided into the survival group  (n=102) and the death group (n=48). Fasting venous blood samples were collected from patients on admission, and the expression levels of serum miR-133a and miR-182-5p were detected by real-time fluorescence quantitative PCR (RT-qPCR). The levels of intestinal barrier function indicators including serum intestinal fatty acid binding protein (IFABP), diamine oxidase (DAO), and D-lactic acid (D-LAC) were detected by enzyme-linked immunosorbent assay (ELISA). The relationship of serum miR-133a and miR-182-5p expression with intestinal barrier and prognosis in patients with sepsis was analyzed. 
Results The intestinal barrier function indicators serum IFABP, DAO, and D-LAC as well as serum miR-133a levels in mild to moderate sepsis group were lower than those in severe sepsis group (t=39.268, 11.414, 13.187, 3.815, all P<0.05), while serum miR-182-5p levels were higher than those in severe sepsis group patients (t=130.137, P<0.05). The results of Pearson correlation analysis showed that serum miR-133a levels were positively correlated with IFABP, DAO, and D-LAC (r=0.421, 0.437, 0.507,all P<0.01), and serum miR-182-5p levels were negatively correlated with IFABP, DAO, and D-LAC (r=-0.433, -0.462, -0.497,all P<0.01). The serum miR-133a level in the survival group was lower than that in the death group (t=10.126, P<0.05), while the serum miR-182-5p level was higher than that in the death group (t=23.979, P<0.05). With prognosis as the dependent variable (1=death, 0=survival), and serum miR-133a and miR-182-5p as independent variables, multivariate Logistic regression analysis showed elevated miR-133a (OR=2.303, 95%CI: 1.453-3.650) and decreased miR-133a (OR=1.772, 95%CI: 1.167-2.690), which were closely related to the prognosis of patients with sepsis (P<0.05). 
Conclusion Serum miR-133a is increased and miR-182-5p is decreased in patients with sepsis, and their levels are closely related to the intestinal barrier function of patients, which has important reference value for the evaluation of patients′ condition and prognosis. 


Key words: sepsis, circulating microRNA, prognosis